Anita Grigoriadis

<i>IDH1</i> and <i>IDH2</i> mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

Maria Fernanda Amary, Krisztián Bácsi, Francesca Maggiani et al. · The Journal of Pathology · 2011 · 994 citations · Full text

Medicine, Genetics, Oncology +16

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Andrew Tutt, Holly Tovey, Maggie C.U. Cheang et al. · Nature Medicine · 2018 · 903 citations · Full text

Medicine, Oncology, Pharmacology +11

BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells

Gemma Molyneux, Felipe C. Geyer, Fiona‐Ann Magnay et al. · Cell stem cell · 2010 · 808 citations · Full text

Medicine, Cancer Biology, Oncology +16

<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Nicholas C. Turner, Alex Pearson, Rachel Sharpe et al. · Cancer Research · 2010 · 738 citations · Full text

Medicine, Cancer Biology, Oncology +17

Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone.

Anita Grigoriadis, Johan N.M. Heersche, Jane E. Aubin · The Journal of Cell Biology · 1988 · 646 citations

Medicine, Developmental Biology, Endocrinology +17